(Q44800086)

6 December 2017

title

Improved survival in severe acquired aplastic anemia of childhood (English)

1 reference

6 December 2017

1 reference

acquired aplastic anemia

1 reference

12

Freedman MH

1 reference

6 December 2017

5

Blanchette V

1 reference

6 December 2017

Fouladi M

1

1 reference

6 December 2017

Herman R

2

1 reference

6 December 2017

Rolland-Grinton M

3

1 reference

6 December 2017

Jones-Wallace D

4

1 reference

6 December 2017

Calderwood S

6

1 reference

6 December 2017

Doyle J

7

1 reference

6 December 2017

Halperin D

8

1 reference

6 December 2017

Leaker M

9

1 reference

6 December 2017

Saunders EF

10

1 reference

6 December 2017

Zipursky A

11

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

Bone Marrow Transplantation

6 December 2017

published in

1 reference

6 December 2017

volume

26

1 reference

6 December 2017

issue

11

1 reference

6 December 2017

page(s)

1149-1156

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702699

6 December 2017

exact match

0 references

cites work

Bone Marrow Graft in Man after Conditioning by Antilymphocytic Serum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702699

Treatment of aplastic anaemia by antilymphocyte globulin with and without allogeneic bone-marrow infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702699

Comparison between bone marrow transplantation and antithymocyte globulin in treatment of young patients with severe aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702699

Immunosuppressive therapy: a potential alternative to bone marrow transplantation as initial therapy for acquired severe aplastic anemia in childhood?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702699

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702699

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702699

Allogeneic bone marrow transplantation for 144 patients with severe aplastic anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702699

Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702699

Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702699

Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702699

Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702699

Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702699

Use of cyclosporin A in allogeneic bone marrow transplantation for severe aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702699

7 January 2021

Improved survival following bone marrow transplantation for aplastic anaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702699

7 January 2021

Bone marrow transplantation in pediatric patients with severe aplastic anemia: cyclophosphamide and anti-thymocyte globulin conditioning followed by recombinant human granulocyte-macrophage colony stimulating factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702699

7 January 2021

Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702699

7 January 2021

Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702699

7 January 2021

Oral cyclosporin-A is effective treatment for untreated and also for previously immunosuppressed patients with severe bone marrow failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702699

7 January 2021

Cyclosporine therapy of aplastic anaemia, congenital and acquired red cell aplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702699

7 January 2021

Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702699

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1702699

1 reference

6 December 2017

1 reference